The document discusses Good Laboratory Practice (GLP), which are regulations created by the FDA in 1978 that provide a framework for conducting laboratory studies. In the early 1970s, the FDA discovered many cases of poor laboratory practices in the US, such as uncalibrated equipment providing incorrect measurements. GLP establish responsibilities for management, sponsors, study directors, investigators, and quality assurance personnel. They also provide guidelines for facility design and maintenance, equipment calibration, test system handling and identification, study planning and reporting, and record keeping. The goal of GLP is to ensure the quality and integrity of nonclinical safety data.